Study: Immunotherapy better than chemotherapy for subtype of head and neck cancer – A randomized clinical…

Study: Immunotherapy better than chemotherapy for subtype of head and neck cancer – A randomized clinical trial involving 97 medical centers in 20 countries, including Moores Cancer Center at UC San Diego Health, found that treating patients who have chemotherapy-resistant head and neck cancer with the immunotherapy drug pembrolizumab is more effective and less toxic than standard chemotherapy, reports an international team of researchers in the November 30 online issue of The Lancet.

Study: Immunotherapy better than chemotherapy for subtype of head and neck cancer

Source: +Medicalxpress
Study: Immunotherapy better than chemotherapy for subtype of head and neck cancer – A randomized clinical…